BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23361573)

  • 1. Osteopontin: participation in inflammation or mucosal protection in inflammatory bowel diseases?
    Chen F; Liu H; Shen Q; Yuan S; Xu L; Cai X; Lian J; Chen SY
    Dig Dis Sci; 2013 Jun; 58(6):1569-80. PubMed ID: 23361573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
    World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin as two-sided mediator of intestinal inflammation.
    Heilmann K; Hoffmann U; Witte E; Loddenkemper C; Sina C; Schreiber S; Hayford C; Holzlöhner P; Wolk K; Tchatchou E; Moos V; Zeitz M; Sabat R; Günthert U; Wittig BM
    J Cell Mol Med; 2009 Jun; 13(6):1162-74. PubMed ID: 18627421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
    Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
    Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
    McAlindon ME; Hawkey CJ; Mahida YR
    Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells.
    Franzè E; Marafini I; De Simone V; Monteleone I; Caprioli F; Colantoni A; Ortenzi A; Crescenzi F; Izzo R; Sica G; Sileri P; Rossi P; Pallone F; Monteleone G
    J Crohns Colitis; 2016 Jan; 10(1):87-94. PubMed ID: 26449789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
    Vetrano S; Rescigno M; Cera MR; Correale C; Rumio C; Doni A; Fantini M; Sturm A; Borroni E; Repici A; Locati M; Malesci A; Dejana E; Danese S
    Gastroenterology; 2008 Jul; 135(1):173-84. PubMed ID: 18514073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
    Sugihara T; Kobori A; Imaeda H; Tsujikawa T; Amagase K; Takeuchi K; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2010 Jun; 160(3):386-93. PubMed ID: 20089077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matriptase protects against experimental colitis and promotes intestinal barrier recovery.
    Netzel-Arnett S; Buzza MS; Shea-Donohue T; Désilets A; Leduc R; Fasano A; Bugge TH; Antalis TM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1303-14. PubMed ID: 22081509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Multiplexed Image Analysis of Intestinal Tissue Sections in Patients With Inflammatory Bowel Disease.
    Kondo A; Ma S; Lee MYY; Ortiz V; Traum D; Schug J; Wilkins B; Terry NA; Lee H; Kaestner KH
    Gastroenterology; 2021 Dec; 161(6):1940-1952. PubMed ID: 34529988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of heat shock protein a4/apg-2 in refractory inflammatory bowel disease.
    Adachi T; Sakurai T; Kashida H; Mine H; Hagiwara S; Matsui S; Yoshida K; Nishida N; Watanabe T; Itoh K; Fujita J; Kudo M
    Inflamm Bowel Dis; 2015 Jan; 21(1):31-9. PubMed ID: 25437815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small heat shock protein CRYAB inhibits intestinal mucosal inflammatory responses and protects barrier integrity through suppressing IKKβ activity.
    Xu W; Guo Y; Huang Z; Zhao H; Zhou M; Huang Y; Wen D; Song J; Zhu Z; Sun M; Liu CY; Chen Y; Cui L; Wang X; Liu Z; Yang Y; Du P
    Mucosal Immunol; 2019 Nov; 12(6):1291-1303. PubMed ID: 31481750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.